Industry Presses NY Governor Not To Sign 1,4-Dioxane Bill, Warns Of Far-Reaching Consequences
Executive Summary
Market disruptions, “dramatically” higher prices, lost jobs and negative health consequences all are possible if legislation passed in New York in June to reduce 1,4-dioxane exposures is enacted in its current form, trade organizations say. Cleaning product industry advocates are leading the opposition, but personal-care manufacturers stand to be impacted as well.
You may also be interested in...
Cosmetics News In Brief: NY Slaps Limit On Cosmetic 1,4-Dioxane Content; J&J Talc Drama; IFF Merger
Suspected trace carcinogen 1,4-dioxane must be limited to 2 parts per million in personal cleansing products sold in New York after 31 December 2022, and 1 ppm one year later, under recently enacted legislation. More cosmetics news in brief.
Imagining A US Where ‘Clean At Sephora’ Is De Facto Law
NGO-backed legislation at US federal, state and local levels to ban cosmetic ingredients and contain contaminant levels would be largely gratuitous if all cosmetics brands were compelled to be “Clean at Sephora.” For now, companies’ adherence to Sephora’s and peers’ green/clean chemistry principles remains voluntary, but retailers’ role as surrogate regulators seems only to be gaining in strength.
US And California Authorities Have 1,4-Dioxane Under Review; Ripple Effects Possible, Attorney Says
Potentially present at trace levels in personal-care products manufactured with ethoxylated materials, 1,4-dioxane is getting regulatory looks from multiple angles at the US state and federal levels. Chemicals law expert Lynn Bergeson of Bergeson & Campbell discusses potential implications for cosmetics industry players.